Patents by Inventor Juan Jose Diaz Garcia
Juan Jose Diaz Garcia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12227540Abstract: Saponin extracts containing at least 93% QS-21 main peak and 0.25-3% 2018 component by UV absorbance at 214 nm, methods for making said extracts, their use as vaccine adjuvants and related aspects.Type: GrantFiled: January 19, 2023Date of Patent: February 18, 2025Assignee: GlaxoSmithKline Biologicals SAInventors: Ahmad Taimour Baig, Felicie Georgette Colette Denet, Juan Jose Diaz Garcia, Chad Austin Farrenburg, Lora Lea Lawrence, Kent Raymond Myers, Jeri Kay Sandvick, Jeb Yeatts Vandenburg
-
Patent number: 12138307Abstract: Crude aqueous extracts of Quillaja saponaria Molina containing at least the QS-21 main peak and 2018 component, wherein the ratio of 2018 component/QS-21 main peak is ?0.075, as measured by UV absorbance at 214 nm, methods for obtaining such extracts and related aspects.Type: GrantFiled: July 17, 2023Date of Patent: November 12, 2024Assignee: GlaxoSmithKline Biologicals SAInventors: Ahmad Taimour Baig, Juan Jose Diaz Garcia, Chad Austin Farrenburg, Kent Raymond Myers, Jeri Kay Sandvick, Jeb Yeatts Vandenburg
-
Publication number: 20240024467Abstract: Crude aqueous extracts of Quillaja saponaria Molina containing at least the QS-21 main peak and 2018 component, wherein the ratio of 2018 component/QS-21 main peak is 0.075, as measured by UV absorbance at 214 nm, methods for obtaining such extracts and related aspects.Type: ApplicationFiled: July 17, 2023Publication date: January 25, 2024Applicant: GLAXOSMITHKLINE BIOLOGICALS SAInventors: Ahmad Taimour BAIG, Juan Jose DIAZ GARCIA, Chad Austin FARRENBURG, Kent Raymond MYERS, Jeri Kay SANDVICK, Jeb Yeatts VANDENBURG
-
Publication number: 20230355752Abstract: Crude aqueous extracts of Quillaja saponaria Molina containing at least the QS-21 main peak and 2018 component, wherein the ratio of 2018 component/QS-21 main peak is ?0.075, as measured by UV absorbance at 214 nm, methods for obtaining such extracts and related aspects.Type: ApplicationFiled: July 17, 2023Publication date: November 9, 2023Applicant: GLAXOSMITHKLINE BIOLOGICALS SAInventors: Ahmad Taimour BAIG, Juan Jose DIAZ GARCIA, Chad Austin FARRENBURG, Kent Raymond MYERS, Jeri Kay SANDVICK, Jeb Yeatts VANDENBURG
-
Patent number: 11744890Abstract: Crude aqueous extracts of Quillaja saponaria Molina containing at least the QS-21 main peak and 2018 component, wherein the ratio of 2018 component/QS-21 main peak is ?0.075, as measured by UV absorbance at 214 nm, methods for obtaining such extracts and related aspects.Type: GrantFiled: November 30, 2018Date of Patent: September 5, 2023Assignee: GlaxoSmithKline Biologicals SAInventors: Ahmad Taimour Baig, Juan Jose Diaz Garcia, Chad Austin Farrenburg, Kent Raymond Myers, Jeri Kay Sandvick, Jeb Yeatts Vandenburg
-
Publication number: 20230272000Abstract: Saponin extracts containing at least 93% QS-21 main peak and 0.25-3% 2018 component by UV absorbance at 214 nm, methods for making said extracts, their use as vaccine adjuvants and related aspects.Type: ApplicationFiled: January 19, 2023Publication date: August 31, 2023Applicant: GLAXOSMITHKLINE BIOLOGICALS SAInventors: Ahmad Taimour BAIG, Felicie Georgette, Colette DENET, Juan Jose DIAZ GARCIA, Chad Austin FARRENBURG, Lora Lea LAWRENCE, Kent Raymond MYERS, Jeri Kay SANDVICK, Jeb Yeatts VANDENBURG
-
Patent number: 11591364Abstract: Saponin extracts containing at least 93% QS-21 main peak and 0.25-3% 2018 component by UV absorbance at 214 nm, methods for making said extracts, their use as vaccine adjuvants and related aspects.Type: GrantFiled: November 30, 2018Date of Patent: February 28, 2023Assignee: GLAXOSMITHKLINE BIOLOGICALS SAInventors: Ahmad Taimour Baig, Felicie Georgette Colette Denet, Juan Jose Diaz Garcia, Chad Austin Farrenburg, Lora Lea Lawrence, Kent Raymond Myers, Jeri Kay Sandvick, Jeb Yeatts Vandenburg
-
Publication number: 20200323980Abstract: Crude aqueous extracts of Quillaja saponaria Molina containing at least the QS-21 main peak and 2018 component, wherein the ratio of 2018 component/QS-21 main peak is ?0.075, as measured by UV absorbance at 214 nm, methods for obtaining such extracts and related aspects.Type: ApplicationFiled: November 30, 2018Publication date: October 15, 2020Applicant: GLAXOSMITHKLINE BIOLOGICALS SAInventors: Ahmad Taimour BAIG, Juan Jose DIAZ GARCIA, Chad Austin FARRENBURG, Kent Raymond MYERS, Jeri Kay SANDVICK, Jeb Yeatts VANDENBURG
-
Publication number: 20200317719Abstract: Saponin extracts containing at least 93% QS-21 main peak and 0.25-3% 2018 component by UV absorbance at 214 nm, methods for making said extracts, their use as vaccine adjuvants and related aspects.Type: ApplicationFiled: November 30, 2018Publication date: October 8, 2020Applicant: GLAXOSMITHKLINE BIOLOGICALS SAInventors: Ahmad Taimour BAIG, Felicie Georgette, Colette DENET, Juan Jose DIAZ GARCIA, Chad Austin FARRENBURG, Lora Lea LAWRENCE, Kent Raymond MYERS, Jeri Kay SANDVICK, Jeb Yeatts VANDENBURG
-
Patent number: 9540416Abstract: The present disclosure concerns methods for producing purified saponins, such as QS-21, which reduces the number of necessary lyophilization cycles to one by a step of solvent exchange and optional subsequent exposure of the purified saponin product to at least one exposure to dry gas followed by exposure to a vacuum to further rid the purified saponin product of residual solvent molecules.Type: GrantFiled: March 14, 2013Date of Patent: January 10, 2017Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.Inventors: Juan Jose Diaz Garcia, Margit Holzer
-
Publication number: 20140030318Abstract: The present disclosure concerns methods for producing purified saponins, such as QS-21, which reduces the number of necessary lyophilization cycles to one by a step of solvent exchange and optional subsequent exposure of the purified saponin product to at least one exposure to dry gas followed by exposure to a vacuum to further rid the purified saponin product of residual solvent molecules.Type: ApplicationFiled: March 14, 2013Publication date: January 30, 2014Applicant: GlaxoSmithKline Biologicals S.A.Inventors: Juan Jose Diaz Garcia, Margit Holzer
